ContractContract • October 6th, 2005 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
*** Confidential treatment has been requested as to certain portions of this contract. Such omitted confidential information has been designated by an asterisk and has been filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended, and the Commission’s rules and regulations promulgated under the Freedom of Information Act, pursuant to a request for confidential treatment.***
